Clinical Trials Logo

Abnormal Karyotype clinical trials

View clinical trials related to Abnormal Karyotype.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT01549548 No longer available - Clinical trials for Chronic Myeloid Leukemia

Compassionate Use Ponatinib

Start date: n/a
Phase: N/A
Study type: Expanded Access

The main purpose of this protocol is to provide expanded access to the study drug (Ponatinib/AP24534) for people with imatinib-, dasatinib-, and nilotinib- resistant/intolerant Philadelphia Chromosome Positive (Ph+) Leukemias. The other purpose of this protocol is to monitor the safety of the study drug in people with Ph+ Leukemias that have not responded to prior treatment.